世界の気管支拡張症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bronchiectasis Therapeutic Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3943 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、気管支拡張症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、去痰薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・気管支拡張症治療の市場動向 ・企業の競争状況、市場シェア ・気管支拡張症治療の種類別市場規模と予測2016-2027（抗生物質、去痰薬、その他） ・気管支拡張症治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・気管支拡張症治療の北米市場規模2016-2027（アメリカ、カナダ） ・気管支拡張症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・気管支拡張症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・気管支拡張症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・気管支拡張症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Alitair Pharmaceuticals Inc.、Bayer AG、Chiesi Farmaceutici SpA、Grifols SA、Insmed Inc、Kamada Ltd、Polyphor Ltd、Recipharm AB） ・結論

Market Analysis and Insights: Global Bronchiectasis Therapeutic Market
The global Bronchiectasis Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bronchiectasis Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bronchiectasis Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bronchiectasis Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bronchiectasis Therapeutic market.

Global Bronchiectasis Therapeutic Scope and Market Size
Bronchiectasis Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bronchiectasis Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibiotics
Expectorants
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Alitair Pharmaceuticals Inc.
Bayer AG
Chiesi Farmaceutici SpA
Grifols SA
Insmed Inc
Kamada Ltd
Polyphor Ltd
Recipharm AB

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchiectasis Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Expectorants
1.2.4 Others
1.3 Market by Application
1.3.1 Global Bronchiectasis Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bronchiectasis Therapeutic Market Perspective (2016-2027)
2.2 Bronchiectasis Therapeutic Growth Trends by Regions
2.2.1 Bronchiectasis Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bronchiectasis Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Bronchiectasis Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Bronchiectasis Therapeutic Industry Dynamic
2.3.1 Bronchiectasis Therapeutic Market Trends
2.3.2 Bronchiectasis Therapeutic Market Drivers
2.3.3 Bronchiectasis Therapeutic Market Challenges
2.3.4 Bronchiectasis Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bronchiectasis Therapeutic Players by Revenue
3.1.1 Global Top Bronchiectasis Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Bronchiectasis Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Bronchiectasis Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bronchiectasis Therapeutic Revenue
3.4 Global Bronchiectasis Therapeutic Market Concentration Ratio
3.4.1 Global Bronchiectasis Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchiectasis Therapeutic Revenue in 2020
3.5 Bronchiectasis Therapeutic Key Players Head office and Area Served
3.6 Key Players Bronchiectasis Therapeutic Product Solution and Service
3.7 Date of Enter into Bronchiectasis Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bronchiectasis Therapeutic Breakdown Data by Type
4.1 Global Bronchiectasis Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Bronchiectasis Therapeutic Forecasted Market Size by Type (2022-2027)

5 Bronchiectasis Therapeutic Breakdown Data by Application
5.1 Global Bronchiectasis Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Bronchiectasis Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bronchiectasis Therapeutic Market Size (2016-2027)
6.2 North America Bronchiectasis Therapeutic Market Size by Type
6.2.1 North America Bronchiectasis Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Bronchiectasis Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Bronchiectasis Therapeutic Market Size by Type (2016-2027)
6.3 North America Bronchiectasis Therapeutic Market Size by Application
6.3.1 North America Bronchiectasis Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Bronchiectasis Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Bronchiectasis Therapeutic Market Size by Application (2016-2027)
6.4 North America Bronchiectasis Therapeutic Market Size by Country
6.4.1 North America Bronchiectasis Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Bronchiectasis Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Bronchiectasis Therapeutic Market Size (2016-2027)
7.2 Europe Bronchiectasis Therapeutic Market Size by Type
7.2.1 Europe Bronchiectasis Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Bronchiectasis Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Bronchiectasis Therapeutic Market Size by Type (2016-2027)
7.3 Europe Bronchiectasis Therapeutic Market Size by Application
7.3.1 Europe Bronchiectasis Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Bronchiectasis Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Bronchiectasis Therapeutic Market Size by Application (2016-2027)
7.4 Europe Bronchiectasis Therapeutic Market Size by Country
7.4.1 Europe Bronchiectasis Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Bronchiectasis Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bronchiectasis Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Bronchiectasis Therapeutic Market Size by Type
8.2.1 Asia-Pacific Bronchiectasis Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bronchiectasis Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bronchiectasis Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Bronchiectasis Therapeutic Market Size by Application
8.3.1 Asia-Pacific Bronchiectasis Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bronchiectasis Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bronchiectasis Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Bronchiectasis Therapeutic Market Size by Region
8.4.1 Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bronchiectasis Therapeutic Market Size (2016-2027)
9.2 Latin America Bronchiectasis Therapeutic Market Size by Type
9.2.1 Latin America Bronchiectasis Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Bronchiectasis Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Bronchiectasis Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Bronchiectasis Therapeutic Market Size by Application
9.3.1 Latin America Bronchiectasis Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Bronchiectasis Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Bronchiectasis Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Bronchiectasis Therapeutic Market Size by Country
9.4.1 Latin America Bronchiectasis Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Bronchiectasis Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bronchiectasis Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Bronchiectasis Therapeutic Market Size by Type
10.2.1 Middle East & Africa Bronchiectasis Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bronchiectasis Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bronchiectasis Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Bronchiectasis Therapeutic Market Size by Application
10.3.1 Middle East & Africa Bronchiectasis Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bronchiectasis Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bronchiectasis Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Bronchiectasis Therapeutic Market Size by Country
10.4.1 Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Bronchiectasis Therapeutic Introduction
11.1.4 GlaxoSmithKline Revenue in Bronchiectasis Therapeutic Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Alitair Pharmaceuticals Inc.
11.2.1 Alitair Pharmaceuticals Inc. Company Details
11.2.2 Alitair Pharmaceuticals Inc. Business Overview
11.2.3 Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Introduction
11.2.4 Alitair Pharmaceuticals Inc. Revenue in Bronchiectasis Therapeutic Business (2016-2021)
11.2.5 Alitair Pharmaceuticals Inc. Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Details
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Bronchiectasis Therapeutic Introduction
11.3.4 Bayer AG Revenue in Bronchiectasis Therapeutic Business (2016-2021)
11.3.5 Bayer AG Recent Development
11.4 Chiesi Farmaceutici SpA
11.4.1 Chiesi Farmaceutici SpA Company Details
11.4.2 Chiesi Farmaceutici SpA Business Overview
11.4.3 Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Introduction
11.4.4 Chiesi Farmaceutici SpA Revenue in Bronchiectasis Therapeutic Business (2016-2021)
11.4.5 Chiesi Farmaceutici SpA Recent Development
11.5 Grifols SA
11.5.1 Grifols SA Company Details
11.5.2 Grifols SA Business Overview
11.5.3 Grifols SA Bronchiectasis Therapeutic Introduction
11.5.4 Grifols SA Revenue in Bronchiectasis Therapeutic Business (2016-2021)
11.5.5 Grifols SA Recent Development
11.6 Insmed Inc
11.6.1 Insmed Inc Company Details
11.6.2 Insmed Inc Business Overview
11.6.3 Insmed Inc Bronchiectasis Therapeutic Introduction
11.6.4 Insmed Inc Revenue in Bronchiectasis Therapeutic Business (2016-2021)
11.6.5 Insmed Inc Recent Development
11.7 Kamada Ltd
11.7.1 Kamada Ltd Company Details
11.7.2 Kamada Ltd Business Overview
11.7.3 Kamada Ltd Bronchiectasis Therapeutic Introduction
11.7.4 Kamada Ltd Revenue in Bronchiectasis Therapeutic Business (2016-2021)
11.7.5 Kamada Ltd Recent Development
11.8 Polyphor Ltd
11.8.1 Polyphor Ltd Company Details
11.8.2 Polyphor Ltd Business Overview
11.8.3 Polyphor Ltd Bronchiectasis Therapeutic Introduction
11.8.4 Polyphor Ltd Revenue in Bronchiectasis Therapeutic Business (2016-2021)
11.8.5 Polyphor Ltd Recent Development
11.9 Recipharm AB
11.9.1 Recipharm AB Company Details
11.9.2 Recipharm AB Business Overview
11.9.3 Recipharm AB Bronchiectasis Therapeutic Introduction
11.9.4 Recipharm AB Revenue in Bronchiectasis Therapeutic Business (2016-2021)
11.9.5 Recipharm AB Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bronchiectasis Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Expectorants
Table 4. Key Players of Others
Table 5. Global Bronchiectasis Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bronchiectasis Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bronchiectasis Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Bronchiectasis Therapeutic Market Share by Regions (2016-2021)
Table 9. Global Bronchiectasis Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Bronchiectasis Therapeutic Market Share by Regions (2022-2027)
Table 11. Bronchiectasis Therapeutic Market Trends
Table 12. Bronchiectasis Therapeutic Market Drivers
Table 13. Bronchiectasis Therapeutic Market Challenges
Table 14. Bronchiectasis Therapeutic Market Restraints
Table 15. Global Bronchiectasis Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Bronchiectasis Therapeutic Market Share by Players (2016-2021)
Table 17. Global Top Bronchiectasis Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchiectasis Therapeutic as of 2020)
Table 18. Ranking of Global Top Bronchiectasis Therapeutic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Bronchiectasis Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bronchiectasis Therapeutic Product Solution and Service
Table 22. Date of Enter into Bronchiectasis Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bronchiectasis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Bronchiectasis Therapeutic Revenue Market Share by Type (2016-2021)
Table 26. Global Bronchiectasis Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Bronchiectasis Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Bronchiectasis Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Bronchiectasis Therapeutic Revenue Market Share by Application (2016-2021)
Table 30. Global Bronchiectasis Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Bronchiectasis Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Bronchiectasis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Bronchiectasis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Bronchiectasis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Bronchiectasis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Bronchiectasis Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Bronchiectasis Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Bronchiectasis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Bronchiectasis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Bronchiectasis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Bronchiectasis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Bronchiectasis Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Bronchiectasis Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Bronchiectasis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Bronchiectasis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bronchiectasis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bronchiectasis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Bronchiectasis Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Bronchiectasis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Bronchiectasis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Bronchiectasis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Bronchiectasis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Bronchiectasis Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Bronchiectasis Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Bronchiectasis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Bronchiectasis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bronchiectasis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bronchiectasis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Bronchiectasis Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Bronchiectasis Therapeutic Product
Table 65. GlaxoSmithKline Revenue in Bronchiectasis Therapeutic Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. Alitair Pharmaceuticals Inc. Company Details
Table 68. Alitair Pharmaceuticals Inc. Business Overview
Table 69. Alitair Pharmaceuticals Inc. Bronchiectasis Therapeutic Product
Table 70. Alitair Pharmaceuticals Inc. Revenue in Bronchiectasis Therapeutic Business (2016-2021) & (US$ Million)
Table 71. Alitair Pharmaceuticals Inc. Recent Development
Table 72. Bayer AG Company Details
Table 73. Bayer AG Business Overview
Table 74. Bayer AG Bronchiectasis Therapeutic Product
Table 75. Bayer AG Revenue in Bronchiectasis Therapeutic Business (2016-2021) & (US$ Million)
Table 76. Bayer AG Recent Development
Table 77. Chiesi Farmaceutici SpA Company Details
Table 78. Chiesi Farmaceutici SpA Business Overview
Table 79. Chiesi Farmaceutici SpA Bronchiectasis Therapeutic Product
Table 80. Chiesi Farmaceutici SpA Revenue in Bronchiectasis Therapeutic Business (2016-2021) & (US$ Million)
Table 81. Chiesi Farmaceutici SpA Recent Development
Table 82. Grifols SA Company Details
Table 83. Grifols SA Business Overview
Table 84. Grifols SA Bronchiectasis Therapeutic Product
Table 85. Grifols SA Revenue in Bronchiectasis Therapeutic Business (2016-2021) & (US$ Million)
Table 86. Grifols SA Recent Development
Table 87. Insmed Inc Company Details
Table 88. Insmed Inc Business Overview
Table 89. Insmed Inc Bronchiectasis Therapeutic Product
Table 90. Insmed Inc Revenue in Bronchiectasis Therapeutic Business (2016-2021) & (US$ Million)
Table 91. Insmed Inc Recent Development
Table 92. Kamada Ltd Company Details
Table 93. Kamada Ltd Business Overview
Table 94. Kamada Ltd Bronchiectasis Therapeutic Product
Table 95. Kamada Ltd Revenue in Bronchiectasis Therapeutic Business (2016-2021) & (US$ Million)
Table 96. Kamada Ltd Recent Development
Table 97. Polyphor Ltd Company Details
Table 98. Polyphor Ltd Business Overview
Table 99. Polyphor Ltd Revenue in Bronchiectasis Therapeutic Business (2016-2021) & (US$ Million)
Table 100. Polyphor Ltd Recent Development
Table 101. Recipharm AB Company Details
Table 102. Recipharm AB Business Overview
Table 103. Recipharm AB Bronchiectasis Therapeutic Product
Table 104. Recipharm AB Revenue in Bronchiectasis Therapeutic Business (2016-2021) & (US$ Million)
Table 105. Recipharm AB Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bronchiectasis Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Expectorants Features
Figure 4. Others Features
Figure 5. Global Bronchiectasis Therapeutic Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Bronchiectasis Therapeutic Report Years Considered
Figure 10. Global Bronchiectasis Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Bronchiectasis Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Bronchiectasis Therapeutic Market Share by Regions: 2020 VS 2027
Figure 13. Global Bronchiectasis Therapeutic Market Share by Regions (2022-2027)
Figure 14. Global Bronchiectasis Therapeutic Market Share by Players in 2020
Figure 15. Global Top Bronchiectasis Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchiectasis Therapeutic as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Bronchiectasis Therapeutic Revenue in 2020
Figure 17. Global Bronchiectasis Therapeutic Revenue Market Share by Type (2016-2021)
Figure 18. Global Bronchiectasis Therapeutic Revenue Market Share by Type (2022-2027)
Figure 19. North America Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Bronchiectasis Therapeutic Market Share by Type (2016-2027)
Figure 21. North America Bronchiectasis Therapeutic Market Share by Application (2016-2027)
Figure 22. North America Bronchiectasis Therapeutic Market Share by Country (2016-2027)
Figure 23. United States Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bronchiectasis Therapeutic Market Share by Type (2016-2027)
Figure 27. Europe Bronchiectasis Therapeutic Market Share by Application (2016-2027)
Figure 28. Europe Bronchiectasis Therapeutic Market Share by Country (2016-2027)
Figure 29. Germany Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bronchiectasis Therapeutic Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Bronchiectasis Therapeutic Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Bronchiectasis Therapeutic Market Share by Region (2016-2027)
Figure 39. China Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bronchiectasis Therapeutic Market Share by Type (2016-2027)
Figure 47. Latin America Bronchiectasis Therapeutic Market Share by Application (2016-2027)
Figure 48. Latin America Bronchiectasis Therapeutic Market Share by Country (2016-2027)
Figure 49. Mexico Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bronchiectasis Therapeutic Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Bronchiectasis Therapeutic Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Bronchiectasis Therapeutic Market Share by Country (2016-2027)
Figure 55. Turkey Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Bronchiectasis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Bronchiectasis Therapeutic Business (2016-2021)
Figure 59. Alitair Pharmaceuticals Inc. Revenue Growth Rate in Bronchiectasis Therapeutic Business (2016-2021)
Figure 60. Bayer AG Revenue Growth Rate in Bronchiectasis Therapeutic Business (2016-2021)
Figure 61. Chiesi Farmaceutici SpA Revenue Growth Rate in Bronchiectasis Therapeutic Business (2016-2021)
Figure 62. Grifols SA Revenue Growth Rate in Bronchiectasis Therapeutic Business (2016-2021)
Figure 63. Insmed Inc Revenue Growth Rate in Bronchiectasis Therapeutic Business (2016-2021)
Figure 64. Kamada Ltd Revenue Growth Rate in Bronchiectasis Therapeutic Business (2016-2021)
Figure 65. Polyphor Ltd Revenue Growth Rate in Bronchiectasis Therapeutic Business (2016-2021)
Figure 66. Recipharm AB Revenue Growth Rate in Bronchiectasis Therapeutic Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---